Non-invasive ventilatory support (NIV) is considered the gold standard in the care of preterm infants with respiratory distress syndrome (RDS). NIV from birth is superior to invasive mechanical ventilation (MV) for the prevention of death or bronchopulmonary dysplasia (BPD) which has significant effects on the patient, associated comorbidities, and impacts on the healthcare system. Various methods of NIV are available, and some of them are extensively researched, such as nCPAP, nasal high-flow cannula, nasal intermittent positive airway pressure ventilation, and bi-level positive airway pressure. These have well-proven efficacy, whilst others need further research, such as nasal high-frequency oscillatory ventilation and nasal neurally adjusted ventilatory assist modes.
The success of NIV support in neonates depends on numerous 'real world' factors that may not be considered in existing controlled studies. These include:
1) Patient factors, such as gestational age (GA), postnatal age, and stage of neonatal lung disease.
2) Device factors, such as the type of NIV used, device-to-patient interface
3) Practice factors such as team experience, skill sets, consistency in practice, and resources of the health service.
The goal of this Research Topic is to identify how these factors contribute to the success or failure of NIV to help guide clinical practice and future research.
This Research Topic will discuss the advantages and complications of non-invasive mechanical ventilation when used as the primary mode of ventilation, or after extubation. Specific themes to be addressed include:
• Comparison of NIV modalities
• Timing and duration of support (especially after extubation)
• Clinical Effectiveness Research
• Optimal settings, team factors, education, practices
• Novel NIV strategies
This Research Topic does not accept case report submissions.
Non-invasive ventilatory support (NIV) is considered the gold standard in the care of preterm infants with respiratory distress syndrome (RDS). NIV from birth is superior to invasive mechanical ventilation (MV) for the prevention of death or bronchopulmonary dysplasia (BPD) which has significant effects on the patient, associated comorbidities, and impacts on the healthcare system. Various methods of NIV are available, and some of them are extensively researched, such as nCPAP, nasal high-flow cannula, nasal intermittent positive airway pressure ventilation, and bi-level positive airway pressure. These have well-proven efficacy, whilst others need further research, such as nasal high-frequency oscillatory ventilation and nasal neurally adjusted ventilatory assist modes.
The success of NIV support in neonates depends on numerous 'real world' factors that may not be considered in existing controlled studies. These include:
1) Patient factors, such as gestational age (GA), postnatal age, and stage of neonatal lung disease.
2) Device factors, such as the type of NIV used, device-to-patient interface
3) Practice factors such as team experience, skill sets, consistency in practice, and resources of the health service.
The goal of this Research Topic is to identify how these factors contribute to the success or failure of NIV to help guide clinical practice and future research.
This Research Topic will discuss the advantages and complications of non-invasive mechanical ventilation when used as the primary mode of ventilation, or after extubation. Specific themes to be addressed include:
• Comparison of NIV modalities
• Timing and duration of support (especially after extubation)
• Clinical Effectiveness Research
• Optimal settings, team factors, education, practices
• Novel NIV strategies
This Research Topic does not accept case report submissions.
